Millennium Management

Millennium Management is an investment management company. They seek an array of investment strategies across industry sectors, asset classes, and geographies. Their entrepreneurial environment enables them to manage their investment processes. They also seek to accelerate by providing sophisticated resources and technology.

12 past transactions

Metagenomi

Series B in 2022
Metagenomi uses metagenomics and machine learning to discover novel genome editing systems for therapeutics development. The company's metagenomics-powered discovery platform and analytical expertise reveal novel cellular machinery sourced from otherwise unknown organisms. Metagenomi forges these naturally evolved systems into powerful gene editing systems that are ultra-small, extremely efficient, highly specific, and have a decreased risk of the immune response. Metagenomi's goal is to revolutionize gene editing for the benefit of patients around the world. The company was founded in 2018 and is headquartered in Emeryville, California.
HFCL is a Company that specializes in manufacturing telecommunication equipment.

Palladyne AI

Post in 2021
Palladyne AI is a leader in advanced robotic technology designed to increase the intelligence, efficiency, capability and productivity of advanced robotic systems. Palladyne AI robotic artificial intelligence and machine learning software enables generalizable autonomy to address challenging, dynamic environments for industries that require a high degree of adaptability and efficiency.

Market Kurly

Series F in 2021
Market Kurly is an online premium grocery service that compares quality and price when looking for good ingredients for foreign goodies. Market Kurly is a food delivery and logistics platform that enables users to order food via the website and receive it the following morning. The company delivers fresh high-end desserts, bread, milk, bottled water, condiments such as flour & salt, processed foods, and more. The company was founded in 2015 and based in Seoul, South Korea.

Payoneer

Post in 2021
Payoneer is a financial technology company that enables small and medium-sized enterprises to transact and thrive.

Quanta

Series D in 2021
Quanta is a medical devices company that develops advanced haemodialysis systems for use in the home and clinic. Quanta is focused on the commercialisation and ongoing development of SC+, an innovative cartridge-based haemodialysis system. SC+ is a high performance, compact haemodialysis system providing clinical efficacy by utilising typical flow rates of traditional in-centre machines. SC+ supports the entire ‘Continuum of Care’ for dialysis patients, from nurse-assisted treatment through self-care in centre to home haemodialysis. Their system facilitates the seamless transition between treatment modalities providing the best tool to enable flexibility for patients, and treatment options for physicians.

Caris Life Sciences

Private Equity Round in 2021
Caris Life Sciences is a molecular science and technology company. They develop and deliver solutions for healthcare and improve cancer patient outcomes. Through molecular profiling and the application of artificial intelligence and machine learning algorithms. They create the clinical-genomic databases and cognitive computing needed to analyze and unravel the molecular complexity of the disease.

Deep Instinct

Series D in 2021
Deep Instinct applies artificial intelligence’s deep learning to cybersecurity. Leveraging deep learning’s predictive capabilities, Deep Instinct’s on-device solution protects against zero-day threats and APT attacks with unmatched accuracy. Deep Instinct safeguards the enterprise’s endpoints and/or any mobile devices against any threat, on any infrastructure, whether or not connected to the network or to the Internet. By applying deep learning technology to cybersecurity, enterprises can now gain unmatched protection against unknown and evasive cyber-attacks from any source. Deep Instinct brings a completely new approach to cybersecurity enabling cyber-attacks to be identified and blocked in real-time before any harm can occur. Deep Instinct USA is headquartered in San Francisco, California and Deep Instinct Israel is headquartered in Tel Aviv, Israel.

Starling Bank

Series D in 2021
Starling Bank provides personal, joint, and business accounts. Their services include digital banking, financial, and accounting services. Their bank accounts manage money in online personal and business banking.

WeDoctor

Series F in 2021
WeDoctor is the world's leading medical health technology platform, created by Liao Jieyuan and his team in 2010. With the mission of “not getting medical care and being healthy and healthy”, WeDoctor is committed to using technology to empower medical care, driving the “medical insurance” ecological upgrade, and building a world-leading HMO (Health Maintenance Organization) platform to provide users with The new medical and health services of “online + offline, general + specialist” have become the health gatekeepers of hundreds of millions of families.

SomaLogic

Series A in 2020
SomaLogic operates as a protein biomarker discovery and clinical diagnostics company. It offers SOMAmers (Slow-Offrate Modified Aptamers), which are modified nucleic acid-based protein-binding reagents that are specific for their cognate protein; and SOMAscan that provides protein detection and equipment. The company’s SOMAmer/SOMAscan technology enables to discover protein biomarker signatures; drug discovery and development; and clinical diagnostics. Its products have applications in the diagnostics of various diseases in oncology, neurology, cardiovascular and metabolic disease, and other diseases and conditions. SomaLogic was founded in 1999 and is headquartered in Boulder, Colorado.

Caris Life Sciences

Private Equity Round in 2020
Caris Life Sciences is a molecular science and technology company. They develop and deliver solutions for healthcare and improve cancer patient outcomes. Through molecular profiling and the application of artificial intelligence and machine learning algorithms. They create the clinical-genomic databases and cognitive computing needed to analyze and unravel the molecular complexity of the disease.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.